Close
Back to XGN Stock Lookup
Pages: 1 2 3 4 5 »» Last Page

Exagen Inc (XGN) – Press Releases

Mar 18, 2024 08:00 AM Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
Mar 8, 2024 09:00 AM Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 8, 2024 09:00 AM Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Mar 7, 2024 04:05 PM Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
Jan 30, 2024 04:05 PM Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 30, 2024 04:05 PM Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 7, 2024 12:00 PM Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
Nov 13, 2023 04:05 PM Exagen Inc. Reports Strong Third Quarter 2023 Results
Nov 9, 2023 04:05 PM Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
Nov 2, 2023 04:05 PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Nov 2, 2023 04:05 PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Oct 30, 2023 04:05 PM Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
Sep 28, 2023 04:05 PM Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
Sep 12, 2023 04:05 PM Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
Aug 7, 2023 08:00 AM Exagen Inc. Reports Strong Second Quarter 2023 Results
Jul 26, 2023 04:05 PM Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Jul 25, 2023 04:05 PM Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
Jul 24, 2023 04:05 PM Exagen Inc. Appoints Paul Kim to Board of Directors
May 30, 2023 09:00 AM Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 15, 2023 04:05 PM Exagen Inc. Reports First Quarter 2023 Results
May 1, 2023 04:05 PM Exagen Announces Campaign for Lupus Awareness Month
May 1, 2023 04:05 PM Exagen Announces Campaign for Lupus Awareness Month
Apr 24, 2023 04:05 PM Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
Apr 24, 2023 04:05 PM Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
Mar 20, 2023 04:05 PM Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
Mar 20, 2023 04:05 PM Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
Mar 6, 2023 04:05 PM Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
Mar 6, 2023 04:05 PM Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
Feb 27, 2023 09:00 AM Exagen Inc. to Participate in Upcoming March Conferences
Feb 27, 2023 09:00 AM Exagen Inc. to Participate in Upcoming March Conferences
Jan 30, 2023 04:05 PM Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 30, 2023 04:05 PM Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan 23, 2023 09:00 AM Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Jan 23, 2023 09:00 AM Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
Nov 14, 2022 04:09 PM Azenta Announces Nomination of Tina S. Nova, Ph.D. and Dorothy E. Puhy to Board of Directors
Nov 14, 2022 04:05 PM Exagen Inc. Reports Third Quarter 2022 Results
Nov 14, 2022 04:05 PM Exagen Inc. Reports Third Quarter 2022 Results
Nov 8, 2022 04:05 PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 8, 2022 04:05 PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Oct 31, 2022 04:05 PM Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Oct 31, 2022 04:05 PM Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Oct 17, 2022 09:00 AM Exagen Announces Appointment of John Aballi as CEO
Oct 17, 2022 09:00 AM Exagen Announces Appointment of John Aballi as CEO
Oct 4, 2022 08:25 AM Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
Oct 4, 2022 08:25 AM Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
Sep 20, 2022 04:05 PM Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
Sep 20, 2022 04:05 PM Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
Sep 1, 2022 04:05 PM Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
Sep 1, 2022 04:05 PM Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
Aug 4, 2022 04:06 PM Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
Pages: 1 2 3 4 5 »» Last Page

Back to XGN Stock Lookup